-
The Multi-modality Cell Segmentation Challenge: Towards Universal Solutions
Authors:
Jun Ma,
Ronald Xie,
Shamini Ayyadhury,
Cheng Ge,
Anubha Gupta,
Ritu Gupta,
Song Gu,
Yao Zhang,
Gihun Lee,
Joonkee Kim,
Wei Lou,
Haofeng Li,
Eric Upschulte,
Timo Dickscheid,
José Guilherme de Almeida,
Yixin Wang,
Lin Han,
Xin Yang,
Marco Labagnara,
Vojislav Gligorovski,
Maxime Scheder,
Sahand Jamal Rahi,
Carly Kempster,
Alice Pollitt,
Leon Espinosa
, et al. (15 additional authors not shown)
Abstract:
Cell segmentation is a critical step for quantitative single-cell analysis in microscopy images. Existing cell segmentation methods are often tailored to specific modalities or require manual interventions to specify hyper-parameters in different experimental settings. Here, we present a multi-modality cell segmentation benchmark, comprising over 1500 labeled images derived from more than 50 diver…
▽ More
Cell segmentation is a critical step for quantitative single-cell analysis in microscopy images. Existing cell segmentation methods are often tailored to specific modalities or require manual interventions to specify hyper-parameters in different experimental settings. Here, we present a multi-modality cell segmentation benchmark, comprising over 1500 labeled images derived from more than 50 diverse biological experiments. The top participants developed a Transformer-based deep-learning algorithm that not only exceeds existing methods but can also be applied to diverse microscopy images across imaging platforms and tissue types without manual parameter adjustments. This benchmark and the improved algorithm offer promising avenues for more accurate and versatile cell analysis in microscopy imaging.
△ Less
Submitted 1 April, 2024; v1 submitted 10 August, 2023;
originally announced August 2023.
-
Drugst.One -- A plug-and-play solution for online systems medicine and network-based drug repurposing
Authors:
Andreas Maier,
Michael Hartung,
Mark Abovsky,
Klaudia Adamowicz,
Gary D. Bader,
Sylvie Baier,
David B. Blumenthal,
Jing Chen,
Maria L. Elkjaer,
Carlos Garcia-Hernandez,
Mohamed Helmy,
Markus Hoffmann,
Igor Jurisica,
Max Kotlyar,
Olga Lazareva,
Hagai Levi,
Markus List,
Sebastian Lobentanzer,
Joseph Loscalzo,
Noel Malod-Dognin,
Quirin Manz,
Julian Matschinske,
Miles Mee,
Mhaned Oubounyt,
Alexander R. Pico
, et al. (14 additional authors not shown)
Abstract:
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining…
▽ More
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining capabilities. To tackle these challenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing. With just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adaptability, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://drugst.one, Drugst.One has significant potential for streamlining the drug discovery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research.
△ Less
Submitted 4 July, 2023; v1 submitted 24 May, 2023;
originally announced May 2023.
-
SIREN Cytoscape plugin: Interaction Type Discrimination in Gene Regulatory Networks
Authors:
Jason Montojo,
Pegah Khosravi,
Vahid H. Gazestani,
Gary D. Bader
Abstract:
Integrating expression data with gene interactions in a network is essential for understanding the functional organization of the cells. Consequently, knowledge of interaction types in biological networks is important for data interpretation. Signing of Regulatory Networks (SIREN) plugin for Cytoscape is an open-source Java tool for discrimination of interaction type (activatory or inhibitory) in…
▽ More
Integrating expression data with gene interactions in a network is essential for understanding the functional organization of the cells. Consequently, knowledge of interaction types in biological networks is important for data interpretation. Signing of Regulatory Networks (SIREN) plugin for Cytoscape is an open-source Java tool for discrimination of interaction type (activatory or inhibitory) in gene regulatory networks. Utilizing an information theory based concept, SIREN seeks to identify the interaction type of pairs of genes by examining their corresponding gene expression profiles. We introduce SIREN, a fast and memory efficient tool with low computational complexity, that allows the user to easily consider it as a complementary approach for many network reconstruction methods. SIREN allows biologists to use independent expression data to predict interaction types for known gene regulatory networks where reconstruction methods do not provide any information about the nature of their interaction types. The SIREN Cytoscape plugin is implemented in Java and is freely available at http://baderlab.org/Software/SIRENplugin and via the Cytoscape app manager.
△ Less
Submitted 16 December, 2015;
originally announced December 2015.
-
The human genome and drug discovery after a decade. Roads (still) not taken
Authors:
Ruth Isserlin,
Gary D. Bader,
Aled Edwards,
Stephen Frye,
Timothy Willson,
Frank H. Yu
Abstract:
The draft sequence of the human genome became available almost a decade ago but the encoded proteome is not being explored to its fullest. Our bibliometric analysis of several large protein families, including those known to be "druggable", reveals that, even today, most papers focus on proteins that were known prior to 2000. It is evident that one or more aspects of the biomedical research system…
▽ More
The draft sequence of the human genome became available almost a decade ago but the encoded proteome is not being explored to its fullest. Our bibliometric analysis of several large protein families, including those known to be "druggable", reveals that, even today, most papers focus on proteins that were known prior to 2000. It is evident that one or more aspects of the biomedical research system severely limits the exploration of the proteins in the 'dark matter' of the proteome, despite unbiased genetic approaches that have pointed to their functional relevance. It is perhaps not surprising that relatively few genome-derived targets have led to approved drugs.
△ Less
Submitted 10 February, 2011; v1 submitted 2 February, 2011;
originally announced February 2011.
